:LATEST NEWS: The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patien

https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm611046.htm